Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

NCT06767332 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT06767332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06767332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
Lead sponsor
Leiden University Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2023
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

eye movement desensitization and reprocessing, familial melanoma, fear of cancer recurrence, psychological intervention